Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a ...

Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia ...

Acute myeloid leukemia, or AML, is a type of cancer that affects the bone marrow and blood. ... Treatment of children with acute myeloid leukemia (AML). (2020). https: ...

Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease Concurrently performed, our trial's primary ...

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that largely affects older adults. Discover the causes, risk factors, how it’s classified, and more information like on ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

At just 11 years old, Aurelia Awa of West Oʻahu has already overcome more challenges than most face in a lifetime. Diagnosed ...

Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer FDA recommends inclusion of patients as young as 6 months – younger than ...

Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ( ...

Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy ...

Background: CBFA2T3::GLIS2-rearranged acute myeloid leukemia (AML) is a rare subtype of AML occurring exclusively in very young children and is associated with poor prognosis ( < 15% 5-year event-free ...